PulseAugur
EN
LIVE 12:16:02

AstraZeneca uses generative AI to discover novel drug scaffolds

AstraZeneca's recent study showcased the effectiveness of generative AI in identifying new and viable chemical scaffolds for clinical use. The success of these AI algorithms is contingent upon their training with vast datasets and ongoing expert oversight from medicinal chemists. AI

IMPACT Generative AI is proving capable of accelerating drug discovery by identifying novel chemical scaffolds, potentially speeding up the development of new medicines.

RANK_REASON The cluster reports on a study detailing the use of AI in drug discovery, which falls under research. [lever_c_demoted from research: ic=1 ai=1.0]

Read on Mastodon — fosstodon.org →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AstraZeneca uses generative AI to discover novel drug scaffolds

COVERAGE [1]

  1. Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] ·

    AstraZeneca’s recent HPK1 study demonstrates that generative # AI can successfully discover novel, clinically viable chemical scaffolds, provided the algorithms

    AstraZeneca’s recent HPK1 study demonstrates that generative # AI can successfully discover novel, clinically viable chemical scaffolds, provided the algorithms are backed by extensive datasets and continuously guided by expert medicinal chemistry judgment. https:// pubs.acs.org/…